Muscle Loss
100
12
15
67
Key Insights
Highlights
Success Rate
99% trial completion (above average)
Research Maturity
67 completed trials (67% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.0%
1 terminated out of 100 trials
98.5%
+12.0% vs benchmark
2%
2 trials in Phase 3/4
9%
6 of 67 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 67 completed trials
Clinical Trials (100)
Combatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treatment Evaluates Whether a 12-week Exercise and Individualized Nutrition Program Can Reduce Muscle and Bone Loss and Improve Strength, Fitness, and Function in Obese Adults on GLP-1
Examining the Effects of Vivo on Physical Function and Glycemic Level in Sedentary Older With Prediabetes.
Multifaceted Intervention Using Telehealth to Reduce the Risk of Falls and Fractures in Older Men
Efficacy of a Water Intervention in Institutionalized Aged Population.
A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)
Ultrasound Detection of Body Composition in Critical Care
Protein and Exercise Training in Chronic KIDNEY Disease
Assessment of Kidney Function and Osteomuscular Status After Critical Care
Preventing Muscle Loss After Bariatric Surgery: Protein-Collagen Supplementation and Resistance Exercise
Mortality and Muscle Mass Loss in Critically Ill Patients.
CFTR Modulator Effects on Bone and Muscle in Adults With Cystic Fibrosis
Pediatric Oncology Nutrition Intervention Trial
Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt
Vivo Prediabetes Study: Online, Live, and Interactive Strength Training for Older Adults With Prediabetes
Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease
Plant vs Animal-based Protein Sources as an Anabolic and Metabolic-protective Options for SO in Older Adults
Study Testing Benefits of Ursolic Acid (UA) as a Countermeasure To Myopenia and Insulin Resistance in Chronic Spinal Cord Injury (SCI)
Impact of Protein and Alkali Supplementation on Skeletal Muscle in Older Adults
Enhanced Bioscaffold for Volumetric Muscle Loss
Biomarkers of Sarcopenia and Frailty in Geriatric Patients